BDTX
Price
$2.50
Change
-$0.12 (-4.60%)
Updated
Jan 23, 04:59 PM (EDT)
Capitalization
141.46M
47 days until earnings call
BPMC
Price
$115.67
Change
+$4.59 (+4.13%)
Updated
Jan 23, 04:59 PM (EDT)
Capitalization
7.35B
20 days until earnings call
Ad is loading...

BDTX vs BPMC

Header iconBDTX vs BPMC Comparison
Open Charts BDTX vs BPMCBanner chart's image
Black Diamond Therapeutics
Price$2.50
Change-$0.12 (-4.60%)
Volume$2.5K
Capitalization141.46M
Blueprint Medicines
Price$115.67
Change+$4.59 (+4.13%)
Volume$18.51K
Capitalization7.35B
BDTX vs BPMC Comparison Chart
Loading...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDTX vs. BPMC commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Hold and BPMC is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 24, 2025
Stock price -- (BDTX: $2.50 vs. BPMC: $115.63)
Brand notoriety: BDTX and BPMC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 152% vs. BPMC: 199%
Market capitalization -- BDTX: $141.46M vs. BPMC: $7.35B
BDTX [@Biotechnology] is valued at $141.46M. BPMC’s [@Biotechnology] market capitalization is $7.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $360.23B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 1 FA rating(s) are green whileBPMC’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 1 green, 4 red.
  • BPMC’s FA Score: 0 green, 5 red.
According to our system of comparison, both BDTX and BPMC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 3 TA indicator(s) are bullish while BPMC’s TA Score has 4 bullish TA indicator(s).

  • BDTX’s TA Score: 3 bullish, 2 bearish.
  • BPMC’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both BDTX and BPMC are a good buy in the short-term.

Price Growth

BDTX (@Biotechnology) experienced а +13.12% price change this week, while BPMC (@Biotechnology) price change was +11.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.04%. For the same industry, the average monthly price growth was +3.42%, and the average quarterly price growth was -1.05%.

Reported Earning Dates

BDTX is expected to report earnings on May 07, 2025.

BPMC is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (+4.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($7.35B) has a higher market cap than BDTX($141M). BPMC YTD gains are higher at: 32.573 vs. BDTX (16.822). BPMC has higher annual earnings (EBITDA): -75.58M vs. BDTX (-81.02M). BPMC has more cash in the bank: 734M vs. BDTX (113M). BDTX has less debt than BPMC: BDTX (23M) vs BPMC (471M). BPMC has higher revenues than BDTX: BPMC (434M) vs BDTX (0).
BDTXBPMCBDTX / BPMC
Capitalization141M7.35B2%
EBITDA-81.02M-75.58M107%
Gain YTD16.82232.57352%
P/E RatioN/AN/A-
Revenue0434M-
Total Cash113M734M15%
Total Debt23M471M5%
FUNDAMENTALS RATINGS
BPMC: Fundamental Ratings
BPMC
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
69
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDTXBPMC
RSI
ODDS (%)
Bullish Trend 16 days ago
77%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 16 days ago
75%
Momentum
ODDS (%)
N/A
Bullish Trend 16 days ago
80%
MACD
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 16 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 16 days ago
90%
Bullish Trend 16 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 16 days ago
75%
Advances
ODDS (%)
N/A
Bullish Trend 17 days ago
72%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 25 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 16 days ago
71%
N/A
Aroon
ODDS (%)
Bearish Trend 16 days ago
86%
Bearish Trend 16 days ago
78%
View a ticker or compare two or three
Ad is loading...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
INPSX38.620.52
+1.36%
ProFunds Internet UltraSector Svc
BSFIX35.590.30
+0.85%
Baron Small Cap Instl
JMNAX14.660.08
+0.55%
JPMorgan Research Market Neutral A
CCCNX7.33N/A
N/A
Center Coast Brookfield Midstream Foc I
FIVUX35.66-0.09
-0.25%
Macquarie Opportunity Instl

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with ACIU. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then ACIU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-4.21%
ACIU - BDTX
54%
Loosely correlated
-0.37%
ABSI - BDTX
38%
Loosely correlated
+3.47%
ZYME - BDTX
36%
Loosely correlated
+1.02%
CRSP - BDTX
35%
Loosely correlated
+0.07%
ABOS - BDTX
35%
Loosely correlated
-1.14%
More

BPMC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BPMC has been loosely correlated with DNLI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BPMC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BPMC
1D Price
Change %
BPMC100%
+4.10%
DNLI - BPMC
44%
Loosely correlated
-0.13%
BEAM - BPMC
43%
Loosely correlated
-0.38%
RXRX - BPMC
43%
Loosely correlated
+0.53%
PDSB - BPMC
42%
Loosely correlated
-10.12%
CRSP - BPMC
42%
Loosely correlated
+0.07%
More